Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bayer
Bayer
Bayer AG opens Kendall Square research center focused on cancer
Boston Globe, MA
Fri, 07/1/22 - 09:46 am
Bayer
Kendall Square
R&D
Boston
innovation
cancer
oncology
Move over Medtech, Pharma Is Embracing AI, Too!
Medical Devices and Diagnostics Industry
Wed, 06/29/22 - 05:29 pm
Medtech
Merck
Bayer
machine learning
artificial intelligence
ADA: Bayer builds its case for potential kidney disease blockbuster Kerendia
Fierce Pharma
Tue, 06/7/22 - 10:13 am
ADA
diabetes
Bayer
chronic kidney disease
Kerendia
Bayer pulls plug on $670M CAR-T cell therapy pact with Atara in wake of patient death
Fierce Biotech
Fri, 05/20/22 - 10:22 am
Bayer
Atara Biotherapeutics
patient death
CAR-T
clinical trials
Bayer's farming business drives Q1 earnings beat
Yahoo/Reuters
Tue, 05/10/22 - 10:53 am
Bayer
earnings
Aiming to treat Parkinson’s by replacing neurons, Aspen Neuroscience nabs $147M
MedCity News
Mon, 05/9/22 - 11:22 pm
Aspen Neuro
Parkinson's Disease
stem cells
Bayer
cell therapy
Bayer's Nubeqa one step closer to blockbuster status thanks to FDA priority review in potential new use
Fierce Pharma
Tue, 05/3/22 - 10:48 pm
Bayer
Nubeqa
prostate cancer
Bayer nabs yet another oncology leader from GSK to bolster cancer efforts
Fierce Biotech
Fri, 04/22/22 - 10:34 am
Bayer
GSK
oncology
First-quarter biotech risers work hard for the win
EP Vantage
Thu, 04/21/22 - 10:32 am
biotech
AbbVie
Bayer
Ipsen
Lantheus Medical
ACC: Bayer’s Kerendia cuts cardio and kidney complications in high-risk patients
Fierce Pharma
Mon, 04/4/22 - 11:20 pm
Bayer
ACC
kidney disease
Kerendia
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Endpoints
Mon, 04/4/22 - 10:56 am
Bayer
bloodthinners
asundexian
clinical trials
Eliquis
Bristol Myers Squibb
JNJ
Bayer reloads Leaps with €1.3 billion to step up investments in biotech innovation
MedCity News
Mon, 04/4/22 - 10:19 am
Bayer
Leaps by Bayer
innovation
artificial intelligence
gene therapy
cell therapy
funding
A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work
Endpoints
Thu, 03/24/22 - 10:53 am
Orion
Bayer
prostate cancer
layoffs
R&D
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
Fierce Biotech
Tue, 03/22/22 - 10:09 am
Affini-T Therapeutics
venture capital
Bayer
KRAS
Steep drop in medical device reports on Bayer's Essure in 2021, FDA data show
Medtech Dive
Wed, 03/16/22 - 10:28 am
devices
Medtech
Bayer
Essure
contraceptives
Amid inflation spike, execs at J&J, Bayer, GSK and more talk higher costs—and what it means for profits
Fierce Pharma
Fri, 03/11/22 - 11:06 am
inflation
JNJ
Bayer
GSK
Viatris
With Bayer's new launches in infancy, Eylea and Xarelto still rule its pharma business—but for how long?
Fierce Pharma
Tue, 03/1/22 - 10:04 pm
Bayer
Eylea
Xarelto
drug launches
Kodiak's Eylea rival hits 'major disappointment' with failure in first of 6 phase 3 studies
Fierce Biotech
Wed, 02/23/22 - 09:28 pm
Kodiak Sciences
KSI-301
Eylea
Bayer
Regeneron
Bayer hikes Nubeqa's peak sales to more than €3B on prostate cancer data, teeing up new 3-way battle against Pfizer-Astellas, J&J
Fierce Pharma
Fri, 02/18/22 - 10:35 am
Bayer
Nubeqa
prostate cancer
Latest data on Bayer's Essure show more patients had device removed: FDA
Medtech Dive
Tue, 02/15/22 - 10:43 am
Bayer
Essure
devices
patients
contraceptives
Medtech
FDA
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »